| Page 919 | Kisaco Research
 

Andrea Iucci

Senior Vice President Europe
IDEXX

Andrea Iucci

Senior Vice President Europe
IDEXX

Andrea Iucci

Senior Vice President Europe
IDEXX

Danjuma Adda

I signed up to AMR Connect for the following: To share challenges of containing AMR in out-patient and community settings, especially in Africa. To have a platform to network and learn new and best practices on improving awareness and behavior change on AMR at community level and to share the results of our AMS activities in Nigeria.

Danjuma Adda

I signed up to AMR Connect for the following: To share challenges of containing AMR in out-patient and community settings, especially in Africa. To have a platform to network and learn new and best practices on improving awareness and behavior change on AMR at community level and to share the results of our AMS activities in Nigeria.

Ghada Zoubiane

The AMR connect is a good conference to join bringing science and policy together to keep advocating for solutions to tackle AMR. It provides an opportunity to share updates both at national and international level while taking a One health approach to the challenge. I hope to be able to share our experience working in partnership with low and middle income countries where the burden is the highest.

Ghada Zoubiane

The AMR connect is a good conference to join bringing science and policy together to keep advocating for solutions to tackle AMR. It provides an opportunity to share updates both at national and international level while taking a One health approach to the challenge. I hope to be able to share our experience working in partnership with low and middle income countries where the burden is the highest.

Andrew Buchanan

When you have well curated data the potential is great. Exploring and validation the potential for prediction functional PD effects. Ultimately using clinical data and insights to design better molecules faster.

Andrew Buchanan

When you have well curated data the potential is great. Exploring and validation the potential for prediction functional PD effects. Ultimately using clinical data and insights to design better molecules faster.

Gian Marco Ghiandoni

I am excited about being able to share some content on how AstraZeneca uses AI/ML to boost productivity and deliver business value. I am as well looking forward to hearing from other people working in my field and possibly coming home with some ideas for my projects.

 

Francesca Hodges

Knowledge Transfer Manager
Innovate UK

Francesca Hodges

Knowledge Transfer Manager
Innovate UK

Francesca Hodges

Knowledge Transfer Manager
Innovate UK

Emilie Louvet

AI is used along the drug discovery and development pipeline: from target discovery, drug design up to commercialization.  Clinical science benefits from AI upon multiple aspects to enable trials design in a faster and more optimal way.